SYNERGISTIC EFFECT AND POSSIBLE MECHANISMS OF TUMOR-NECROSIS-FACTOR AND CISPLATIN CYTOTOXICITY UNDER MODERATE HYPERTHERMIA AGAINST GASTRIC-CANCER CELLS

Citation
Jf. Buell et al., SYNERGISTIC EFFECT AND POSSIBLE MECHANISMS OF TUMOR-NECROSIS-FACTOR AND CISPLATIN CYTOTOXICITY UNDER MODERATE HYPERTHERMIA AGAINST GASTRIC-CANCER CELLS, Annals of surgical oncology, 4(2), 1997, pp. 141-148
Citations number
44
Categorie Soggetti
Surgery,Oncology
Journal title
ISSN journal
10689265
Volume
4
Issue
2
Year of publication
1997
Pages
141 - 148
Database
ISI
SICI code
1068-9265(1997)4:2<141:SEAPMO>2.0.ZU;2-K
Abstract
Background: Peritoneal carcinomatosis is a difficult management proble m, and intraperitoneal treatment approaches may provide an opportunity to intensify dose and minimize toxicity. The current experiments were conducted to characterize the cytotoxic effects of cisplatin (cDDP), tumor necrosis factor (TNF), and hyperthermia (HT) on a gastric cancer cell line in vitro under conditions achievable with intraperitoneal t reatment. Methods: Seoul National University gastric cancer cell line (SNU-5), a poorly differentiated gastric cancer cell line, was tested for sensitivity to various doses of cDDP, TNF, or combinations of the two at normothermia (37 degrees C) or HT (42.5 degrees C). The effect of TNF on cellular rates of cDDP accumulation, efflux, and cDDP-DNA ad duct formation were evaluated using atomic absorbance spectrometry wit h Zeemen background correction. Results: During a 2-h exposure to vari ous doses of cDDP with HT, we observed a supraadditive cytotoxicity of SNU-5 with 1 to 50 mu g/ml of TNF (p(2) = 0.0001). In the presence of the three-agent combination (HT, TNF, and cDDP) we observed statistic ally significant increases in total cellular accumulation of cisplatin (p(2) = 0.016); a nonsignificant decrease in cellular efflux of drug (p(2) = 0.098); and a 40% increase in persistent cisplatin DNA damage as measured by atomic absorption spectrophotometry (p(2) = 0.06). Thes e patterns were specifically not seen with the combinations of cDDP an d HT, or cDDP and TNF. Conclusions: These data provide the experimenta l basis for the use of TNF and cDDP with HT in the treatment of gastri c cancer and support the investigation of these agents in vivo in the regional treatment of peritoneal carcinomatosis.